The human heart is a simple yet efficient mechanical pump. Simulating it as a prosthetic organ has been challenging to bioengineers, to say the least.
Biomedical engineers and inventors have tried unsuccessfully over half a century, to duplicate it, with results that have numerous limitations in material design as well as function. The challenges to create a permanent implantable artificial heart are multifold:
- (1) sustainability
- (2) thrombus formation
- (3) scalable size
- (4) power regeneration
- (5) pressure regulation and
- (6) biocompatibility/immune modulated rejection.
Parace Bionics, LLC has pioneered an innovative technology that may overcome many of the challenges noted, for a resultant prosthetic heart with improvements in design as well as function.
Our revolutionary technology uses a proprietary method to simulate the natural pumping mechanism of the human heart in a manner which closely mimics the physiological mechanics of the human circulatory system. Additionally, concerns about power regeneration are mitigated by a proprietary revolutionary battery source.
MICROVAD™ (TAH) technology will generate a measurable blood pressure, autonomic electricity ability as well as a palpable pulse – just like the human heart.
Further, the MICROVAD™ will be able to recharge its battery, thereby prolonging its daily use and lifespan (Cardio-Generator).
We have recognized that “electric motor based” cardiac technologies have many limitations & drawbacks (with measurable benefits in some instances), which have been tried and proven to be self-limiting for numerous reasons. The size & energy consumption of electric motor power systems prohibit application of these devices in the pediatric population, women and average size humans. The MICROVAD™ will be the first technology to depart from conventional hardware, to build a revolutionary device that will “leap frog” the challenges of achieving a truly bionic heart that can adapt to all walks of life.
The longest a patient has every lived with an “electric motor” power implanted TAH device has been less than two years. The FDA has placed “Humanitarian” indications for other forms of “electric motor” TAHs, which have been developed within the last decade.
Clearly a new approach is required to address an overdue need for an efficient TAH. Parace Bionics is developing such a technology to meet this dire need in the cardiac space.
We welcome humanitarian and philanthropic inquiries for this technology.